Jane Henderson insider trades: Apogee Therapeutics (APGE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jane reports to the SEC
and 5 more companies
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | APGE | ↓ Sell | 2,000 | $82.04 | $164K | Direct | May 4, 2026 (3d) |
| Apr 16, 2026 | APGE | ↓ Sell | 2,000 | $90.00 | $180K | Direct | Apr 17, 2026 (1d) |
| Apr 1, 2026 | APGE | ↓ Sell | 2,000 | $85.01 | $170K | Direct | Apr 3, 2026 (2d) |
| Mar 2, 2026 | APGE | ↓ Sell | 2,000 | $70.22 | $140K | Direct | Mar 4, 2026 (2d) |
| Feb 2, 2026 | APGE | ↓ Sell | 2,000 | $65.81 | $132K | Direct | Feb 4, 2026 (2d) |
| Jan 6, 2026 | APGE | ↓ Sell | 8,000 | $76.14 | $609K | Direct | Jan 6, 2026 (0d) |
| Dec 19, 2025 | APGE | ↓ Sell | 1,500 | $80.00 | $120K | Direct | Dec 23, 2025 (4d) |
| Dec 4, 2025 | APGE | ↓ Sell | 1,500 | $75.00 | $113K | Direct | Dec 5, 2025 (1d) |
| Nov 25, 2025 | APGE | ↓ Sell | 1,500 | $70.00 | $105K | Direct | Nov 28, 2025 (3d) |
| Nov 14, 2025 | APGE | ↓ Sell | 2,000 | $65.00 | $130K | Direct | Nov 14, 2025 (0d) |
| Nov 11, 2025 | APGE | ↓ Sell | 1,000 | $60.00 | $60K | Direct | Nov 13, 2025 (2d) |
| Aug 12, 2025 | AKRO | ↓ Sell | 3,000 | $47.46 | $142K | Direct | Aug 12, 2025 (0d) |
| Aug 23, 2024 | APGE | ↓ Sell | 6,000 | $48.26 | $290K | Direct | Aug 23, 2024 (0d) |
| Jun 16, 2023 | AKRO | ↓ Sell | 40,000 | $54.17 | $2.2M | Direct | Jun 21, 2023 (5d) |
| Mar 23, 2018 | VYGR | ↓ Sell | 31,100 | $20.87 | $649K | Direct | Mar 26, 2018 (3d) |
| Mar 19, 2018 | VYGR | ↓ Sell | 17,316 | $22.11 | $383K | Direct | Mar 20, 2018 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other APGE insiders
Open-market trades in the last 12 months
About Jane Henderson's insider trades
Jane Henderson is Chief Financial Officer at Apogee Therapeutics (APGE). Since Mar 19, 2018, Jane has reported no open-market purchases and 16 sales worth $5.6M on SEC Form 4. In the last 12 months: 11 sales ($1.9M).
Their filings also include grants and awards (31 filings), option exercises (6 filings), shares returned to the company (4 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every APGE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.